Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre (Jan, 2022, 10.1007/s00415-021-10958-z)

被引：0

作者：

Cobo-Calvo, Alvaro ^{[1
]}

Zabalza, Ana ^{[1
]}

Rio, Jordi ^{[1
]}

Arrambide, Georgina ^{[1
]}

Otero-Romero, Susana ^{[1
]}

Tagliani, Paula ^{[1
]}

Cardenas-Robledo, Simon ^{[1
]}

Castillo, Mireia ^{[1
]}

Espejo, Carmen ^{[1
]}

Rodriguez, Marta ^{[1
]}

Carbonell, Pere ^{[1
]}

Rodriguez, Breogan ^{[1
]}

Midaglia, Luciana ^{[1
]}

Vidal-Jordana, Angela ^{[1
]}

Tur, Carmen ^{[1
]}

Galan, Ingrid ^{[1
]}

Castillo, Joaquin ^{[1
]}

Comabella, Manuel ^{[1
]}

Nos, Carlos ^{[1
]}

Auger, Cristina ^{[2
]}

Tintore, Mar ^{[1
]}

Rovira, Alex ^{[2
]}

Montalban, Xavier ^{[1
]}

Sastre-Garriga, Jaume ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Ctr Esclerosi Multiple Catalunya Cemcat, Dept Neurol Neuroimmunol, Edifici Cemcat,Vall Hebron Inst Recerca,Hosp Univ, Pg Vall Hebron 119-129, Barcelona 08035, Spain

[2] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Vall Hebron Inst, Sect Neuroradiol & Magnet Resonance Unit,Dept Rad, Barcelona, Spain

来源：

JOURNAL OF NEUROLOGY | 2022年 / 269卷 / 04期

关键词：

COVID-19; Multiple sclerosis; SARS-CoV-2; Standards of care;

D O I：

10.1007/s00415-022-11019-9

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction: To evaluate the impact of the COVID-19 pandemic on (1) number of clinical visits, (2) magnetic resonance (MR) scans, and (3) treatment prescriptions in a multiple sclerosis (MS) referral centre. Methods: Retrospective study covering January 2018 to May 2021. Results: The monthly mean (standard deviation [SD]) of visits performed in 2020 (814[137.6]) was similar to 2018 (741[99.7]; p = 0.153), and 2019 (797[116.3]; p = 0.747). During the COVID-19 period (2020 year), 36.3% of the activity was performed through telemedicine. The number of MR scans performed dropped by 76.6% during the “first wave” (March 14 to June 21, 2020) compared to the mean monthly activity in 2020 (183.5[68.9]), with a recovery during the subsequent two months. The monthly mean of treatment prescriptions approved in 2020 (24.1[7.0]) was lower than in 2019 (30[7.0]; p = 0.049), but similar to 2018 (23.8[8.0]; p = 0.727). Natalizumab prescriptions increased in the “first wave” and onwards, whereas anti-CD20 prescriptions decreased during the COVID-19 period. Conclusion: Maintenance of the number of clinical visits was likely due to telemedicine adoption. Although the number of MR dramatically dropped during the “first wave”, an early recovery was observed. Treatment prescriptions suffered a slight quantitative decrease during 2020, whereas substantial qualitative changes were found in specific treatments. © 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

引用

页码：1773 / 1773

页数：1

共 1 条

[1] Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre
Alvaro Cobo-Calvo
Ana Zabalza
Jordi Río
Georgina Arrambide
Susana Otero-Romero
Paula Tagliani
Simón Cárdenas-Robledo
Mireia Castillo
Carmen Espejo
Marta Rodriguez
Pere Carbonell
Breogán Rodríguez
Luciana Midaglia
Ángela Vidal-Jordana
Carmen Tur
Ingrid Galan
Joaquín Castillo
Manuel Comabella
Carlos Nos
Cristina Auger
Mar Tintoré
Àlex Rovira
Xavier Montalban
Jaume Sastre-Garriga
Journal of Neurology, 2022, 269 : 1773 - 1773

← 1 →